Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.

about

Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.

Item

http://www.wikidata.org/entity/Q42262074

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@en

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@nl

type

Item

label

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@en

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@nl

prefLabel

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@en

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@nl

P1476

Additive Effect of Oral Steroi ...... ents with Epiretinal Membrane.

@en

P2093

Mee Kum Kim

http://www.w3.org/2001/XMLSchema#string

Seonghwan Kim

http://www.w3.org/2001/XMLSchema#string

Won Ryang Wee

http://www.w3.org/2001/XMLSchema#string

P2860

Angiostatic steroids. Method of discovery and mechanism of action

Cataract surgery and diabetes.

Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification.

The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.

The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update.

Diagnostic and therapeutic approach to patients with retinal vasculitis.

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.

Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care.

P304

394-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3341/KJO.2016.0109

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28913997

http://www.w3.org/2001/XMLSchema#string

P932

5636715

http://www.w3.org/2001/XMLSchema#string